Drug Database
DU

DuraSolv (DuraSolv)

✓ Approved

Teva Pharmaceutical Industries Ltd. · therapeutic agent

What is DuraSolv?

DuraSolv is a therapeutic agent developed by Teva Pharmaceutical Industries Ltd.. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesDuraSolv
CompanyTeva Pharmaceutical Industries Ltd.
RouteOral (PO)
StatusApproved

Therapeutic Indications

DuraSolv is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Surgical and medical proceduresOral appliance application✓ Approved

Related Research Articles

PubMedActa pharmaceutica (Zagreb, Croatia)2011-06-21

The technologies used for developing orally disintegrating tablets: a review.

Badgujar Bhatu P BP, Mundada Atish S AS

Orally disintegrating tablets (ODTs), also known as fast melts, quick melts, fast disintegrating and orodispersible systems, have the unique property of disintegrating in the mouth in seconds without chewing and the need of water and are thus assumed to improve patient compliance. Conventional methods like direct compression, wet granulation, moulding, spray-drying, freeze-drying and sublimation were used to prepare ODTs. New advanced technologies like Orasolv®, Durasolv®, Wowtab®, Flashtab®, Zydis®, Flashdose®, Oraquick®, Lyoc®, Advatab®, Frosta®, Quick-Disc® and Nanomelt® have been introduced by some pharmaceutical companies for the production of ODTs. The main objective of this review is to give a comprehensive insight into conventional and recent technologies used for the preparation of ODTs.

Ask about DuraSolv